ABBV Abbvie Inc

AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.

$153.80  +0.64 (0.42%)
As of 07/01/2022 16:04:32 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  USA
Country of incorporation:  USA
IPO date:  12/10/2012
Outstanding shares:  1,767,110,083
Average volume:  6,245,294
Market cap:   $270,650,580,312
Current dividend yield:  3.49%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B92SR70
Valuation   (See tab for details)
PE ratio:   21.78
PB ratio:   16.69
PS ratio:   4.77
Return on equity:   76.64%
Net income %:   22.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy